Use of ghrelin and unacylated ghrelin compositions for treating insulin resistance
US7825090B2 · kind B2 · utility
6Cited by
2References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2004 |
| Grant date | Nov 2, 2010 |
| Priority date | — |
| Expiry date | Mar 22, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel combination of ghrelin and unacylated ghrelin is described herein. Methods of administering and uses of this combination to alter an insulin-associated parameter are also described. Compositions and packages containing ghrelin and/or one of its analogs and nonacylated ghrelin and/or one of its analogs as well as the uses of such compositions in providing therapeutic benefit to human patients diagnosed with for example insulin resistance, diabetes and obesity are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.